Pnina Fishman

Pnina Fishman

Company: Can Fite BioPharma

Job title: Chief Executive Officer


Piclidenoson for the Treatment of Psoriasis: Clinical Development and Mechanism of Drug Action 2:30 pm

Highlighting key findings from phase 2 small molecule study orally administered to psoriasis patients Leveraging phase 2 PI3K modulation results to enhance phase 3 clinical trials Over-viewing the potential for repositioning of Piclidenoson into alternative inflammatory indicationsRead more

day: Day 1 PM - Track B

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.